Literature DB >> 28167350

Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses.

Kamin Kim1, Martijn L T M Müller2, Nicolaas I Bohnen3, Martin Sarter4, Cindy Lustig5.   

Abstract

Successful behavior depends on the ability to detect and respond to relevant cues, especially under challenging conditions. This essential component of attention has been hypothesized to be mediated by multiple neuromodulator systems, but the contributions of individual systems (e.g., cholinergic, dopaminergic) have remained unclear. The present study addresses this issue by leveraging individual variation in regionally-specific cholinergic denervation in Parkinson's disease (PD) patients, while controlling for variation in dopaminergic denervation. Patients whose dopaminergic and cholinergic nerve terminal integrity had been previously assessed using Positron Emission Tomography (Bohnen et al., 2012) and controls were tested in a signal detection task that manipulates attentional-perceptual challenge and has been used extensively in both rodents and humans to investigate the cholinergic system's role in responding to such challenges (Demeter et al., 2008; McGaughy and Sarter, 1995; see Hasselmo and Sarter 2011 for review). In simple correlation analyses, measures of midbrain dopaminergic, and both cortical and thalamic cholinergic innervation all predicted preserved signal detection under challenge. However, regression analyses also controlling for age, disease severity, and other variables showed that the only significant independent neurotransmitter-related predictor over and above the other variables in the model was thalamic cholinergic integrity. Furthermore, thalamic cholinergic innervation exclusively predicted hits, not correct rejections, indicating a specific contribution to bottom-up salience processing. These results help define regionally-specific contributions of cholinergic function to different aspects of attention and behavior.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28167350      PMCID: PMC5386784          DOI: 10.1016/j.neuroimage.2017.02.006

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  98 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies.

Authors:  Matthew T Sutherland; Kimberly L Ray; Michael C Riedel; Julio A Yanes; Elliot A Stein; Angela R Laird
Journal:  Biol Psychiatry       Date:  2015-01-07       Impact factor: 13.382

3.  Neurons in the basal forebrain project to the cortex in a complex topographic organization that reflects corticocortical connectivity patterns: an experimental study based on retrograde tracing and 3D reconstruction.

Authors:  Laszlo Zaborszky; Attila Csordas; Kevin Mosca; Joseph Kim; Matthew R Gielow; Csaba Vadasz; Zoltan Nadasdy
Journal:  Cereb Cortex       Date:  2013-08-19       Impact factor: 5.357

4.  Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.

Authors:  Franz Faul; Edgar Erdfelder; Axel Buchner; Albert-Georg Lang
Journal:  Behav Res Methods       Date:  2009-11

5.  Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.

Authors:  Vikas Kotagal; Martijn L T M Müller; Daniel I Kaufer; Robert A Koeppe; Nicolaas I Bohnen
Journal:  Neurosci Lett       Date:  2012-03-03       Impact factor: 3.046

6.  Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.

Authors:  S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

Review 7.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

8.  Rats and humans paying attention: cross-species task development for translational research.

Authors:  Elise Demeter; Martin Sarter; Cindy Lustig
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

9.  Cholinergic enhancement reduces spatial spread of visual responses in human early visual cortex.

Authors:  Michael A Silver; Amitai Shenhav; Mark D'Esposito
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

Review 10.  Thalamic neuromodulation and its implications for executive networks.

Authors:  Carmen Varela
Journal:  Front Neural Circuits       Date:  2014-06-24       Impact factor: 3.492

View more
  20 in total

Review 1.  Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board.

Authors:  Roger L Albin; D James Surmeier; Cecilia Tubert; Martin Sarter; Martijn L T M Müller; Nicolaas I Bohnen; William T Dauer
Journal:  Mov Disord       Date:  2018-11-06       Impact factor: 10.338

Review 2.  Dichotomy between motor and cognitive functions of midbrain cholinergic neurons.

Authors:  Nadine K Gut; Juan Mena-Segovia
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

Review 3.  Cholinergic double duty: cue detection and attentional control.

Authors:  Martin Sarter; Cindy Lustig
Journal:  Curr Opin Psychol       Date:  2019-01-04

4.  Repetitive mild concussion in subjects with a vulnerable cholinergic system: Lasting cholinergic-attentional impairments in CHT+/- mice.

Authors:  Ajeesh Koshy Cherian; Natalie C Tronson; Vinay Parikh; Aaron Kucinski; Randy D Blakely; Martin Sarter
Journal:  Behav Neurosci       Date:  2019-03-21       Impact factor: 1.912

5.  The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.

Authors:  Kamin Kim; Martijn L T M Müller; Nicolaas I Bohnen; Martin Sarter; Cindy Lustig
Journal:  Neuroimage       Date:  2017-12-19       Impact factor: 6.556

Review 6.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

7.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

8.  Increased on-state cortico-mesencephalic functional connectivity in Parkinson disease with freezing of gait.

Authors:  Daniel H Lench; Aaron Embry; Alyssa Hydar; Colleen A Hanlon; Gonzalo Revuelta
Journal:  Parkinsonism Relat Disord       Date:  2020-02-19       Impact factor: 4.891

9.  Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease.

Authors:  Kamin Kim; Nicolaas I Bohnen; Martijn L T M Müller; Cindy Lustig
Journal:  Neuroimage       Date:  2018-01-11       Impact factor: 6.556

10.  Regional vesicular acetylcholine transporter distribution in human brain: A [18 F]fluoroethoxybenzovesamicol positron emission tomography study.

Authors:  Roger L Albin; Nicolaas I Bohnen; Martijn L T M Muller; William T Dauer; Martin Sarter; Kirk A Frey; Robert A Koeppe
Journal:  J Comp Neurol       Date:  2018-10-19       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.